[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344043-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344043-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mirna-22-3p-inhibits-cell-viability-and-metastasis-of-nasopharyngeal-carcinoma-by-targeting-foxp1","miRNA‑22‑3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1","","Nasopharyngeal carcinoma (NPC) is a malignant tumor with high incidence in certain regions. The study evaluates the biological role of microRNA (miRNA/miR)‑22‑3p in NPC progression, focusing on cell viability and migration. Transwell, wound healing and Cell Counting Kit‑8 assays assessed HK‑1 cell viability and migration. Epithelial‑mesenchymal transition markers (E‑cadherin, vimentin, N‑cadherin) were examined by western blot. miRNA‑22‑3p levels were reduced in NPC tissues and cell lines. Overexpression suppressed viability and migration and acted as a molecular sponge for FOXP1; FOXP1 overexpression reversed these effects, supporting miRNA‑22‑3p as a therapeutic biomarker.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mirna-22-3p-inhibits-cell-viability-and-metastasis-of-nasopharyngeal-carcinoma-by-targeting-foxp1/344043/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mirna-22-3p-inhibits-cell-viability-and-metastasis-of-nasopharyngeal-carcinoma-by-targeting-foxp1/344043.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on miRNA‑22‑3p in NPC?","Question",{"text":63,"@type":64},"To determine how miRNA‑22‑3p affects NPC cell viability and migration and to clarify its underlying molecular mechanism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers measure NPC cell viability and migration?",{"text":68,"@type":64},"HK‑1 cell viability and migration were evaluated using Transwell, wound healing, and Cell Counting Kit‑8 assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does FOXP1 play according to the study results?",{"text":72,"@type":64},"The dual luciferase reporter assay indicated miRNA‑22‑3p directly targets FOXP1, and FOXP1 overexpression counteracted miRNA‑22‑3p–induced inhibition.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344043,1790193068,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":118,"preview_page_count":33,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","ONCOLOGY LETTERS 29: 96, 2025  \nmiRNA‑22‑3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1  \n* *  \nYING JIN , ZHIJUN WANG , YUANSHAN LIANG, YITING JIANG, FAYANG YUAN and TIAN ZHANG  \nDepartment of Otorhinolaryngology Head and Neck Surgery,  \nAffiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China  \nReceived June 28, 2024; Accepted November 4, 2024  \nDOI: 10. 3892/ol.2024.14842  \nAbstract. Nasopharyngeal carcinoma (NPC) is a malignant tumor with a high incidence rate in certain regions. MicroRNA (miRNA/miR)‑22‑3p is implicated in the regulation of tumorigenesis and progression. However, the biological role of miRNA‑22‑3p in the progression of NPC remains unclear. The present study aimed to assess the effects of miRNA‑22‑3poverexpression on the cell viability and migration of NPC cells . The cell viability and migration of HK‑1 cells was evaluated using Transwell, wound healing and Cell Counting Kit‑8 assays. To assess the epithelial‑mesenchymal transition ability of NPC cells, the expression of E‑cadherin, vimentin and N‑cadherin was evaluated using western blot analysis. The results revealed expression of miRNA‑22‑3p was significantly decreased in NPC tissues compared with para‑cancerous tissues . Decreased expression of miRNA‑22‑3p was also observed in NPC cell lines (C666‑1 and HK‑1) . The overex‑ pression of miRNA‑22‑3p reduced HK‑1 cell viability and migration. In addition, a dual luciferase reporter assay revealed that miRNA‑22‑3p functioned as a molecular sponge for fork‑ head box protein 1 (FOXP1) . Notably, FOXP1 overexpression counteracted the suppressive effects induced by transfection with miRNA‑22‑3p mimic on HK‑1 cell viability and migra‑ tion. Therefore, these data indicate that miRNA‑22‑3p may bea clinically valuable biomarker for the therapy of NPC.  \nIntroduction  \nNasopharyngeal carcinoma (NPC) is a malignant neoplasm originating from the parietal epithelial cells of the  \nCorrespondence to: Professor Tian Zhang, Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Guizhou Medical University, 28 Guiyi Street, Yunyan, Guiyang, Guizhou 550004, P.R. China  \nE‑mail: [entzhangtian@126.com](entzhangtian@126.com)  \n*Contributed equally  \nKey words: microRNA‑22‑3p, forkhead box protein 1, nasopharyngeal carcinoma, cancer progression  \nnasopharynx (1) . It is the most prevalent type of cancer inotorhinolaryngology, with age‑standardized rates typically \u003C1 per 100,000 person‑years (2) . NPC is distinguished by its localized distribution, complex etiology, subtle onset, exten‑ sive metastasis and high invasiveness (1). The primary clinical strategy for the management of NPC is radiotherapy, albeit with numerous adverse effects (1,3) . While the combination of chemo‑radiotherapy yields a satisfactory 5‑year survival rate of 85‑90%, a recurrence and tumor metastasis still occur in 8‑10% of patients (4) . Hence, exploring its pathogenesis and identifying novel drugs and therapeutic targets is of utmost importance.  \nMicroRNAs (miRNAs/miRs) are a class of small RNA molecules (19‑24 nucleotides in length) that exert regula‑ tory control over gene expression by selectively binding and impeding the translation of specific mRNA molecules (5‑7) . These molecules occupy a pivotal position in a multitude of biological processes, encompassing developmental events, cellular signaling cascades and metabolic pathways (5,8) . In tumorigenesis, miRNAs can function as either oncogenes or tumor suppressors, serves a crucial role in the regulation of cell proliferation, apoptosis, invasion and metastasis (9) . The dysregulation of miRNA expression (such as miRNA‑106a‑5p, miRNA‑9 and miRNA‑194) has been observed in NPC, contributing to aberrant cellular growth and the development of NPC (10,11) .  \nAmong the numerous miRNAs identified, miRNA‑22‑3p has emerged as a novel cancer‑associated miRNA. A previous study indicated that repression of miRNA","cbCaiiPjAZDSUgV2","https://ap.wps.com/l/cbCaiiPjAZDSUgV2","pdf",6780124,"English","# Abstract\n# Introduction\n# Materials and methods","[{\"question\":\"What is the main purpose of the study on miRNA‑22‑3p in NPC?\",\"answer\":\"To determine how miRNA‑22‑3p affects NPC cell viability and migration and to clarify its underlying molecular mechanism.\"},{\"question\":\"How did the researchers measure NPC cell viability and migration?\",\"answer\":\"HK‑1 cell viability and migration were evaluated using Transwell, wound healing, and Cell Counting Kit‑8 assays.\"},{\"question\":\"What role does FOXP1 play according to the study results?\",\"answer\":\"The dual luciferase reporter assay indicated miRNA‑22‑3p directly targets FOXP1, and FOXP1 overexpression counteracted miRNA‑22‑3p–induced inhibition.\"}]","miRNA‑22‑3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1 | PDF",1790052851,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21f7b081767af41df0be4a56a9429703.webp",983,1357,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d9d60df81057123d05938025404826.webp",982,1356,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f68ba2ff2eb3f2408e7b07c41e3b70b.webp",981,1354,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/164cb6b7e67547690bf7924cf863445e.webp",980,1353]